What qualifies you for Vyvanse? An overview of diagnostic criteria and prescribing guidelines
•
5 min read
According to the FDA, Vyvanse (lisdexamfetamine) is approved for treating Attention-Deficit/Hyperactivity Disorder (ADHD) and moderate to severe Binge Eating Disorder (BED) in adults. For those considering this medication, understanding what qualifies you for Vyvanse, beyond just the diagnosis, is the critical first step in the treatment process.
